questionsmedicales.fr
Acides aminés, peptides et protéines
Protéines
Globulines
Sérum-globulines
Immunoglobulines
Anticorps
Autoanticorps
Anticorps antiphospholipides
Anticorps anticardiolipines
Anticorps anticardiolipines : Questions médicales fréquentes
Diagnostic
5
Anticorps anticardiolipines
Syndrome des antiphospholipides
Tests de laboratoire
Anticorps anticardiolipines
Thrombose
Anticorps anticardiolipines
Anticorps anticardiolipines
Maladies auto-immunes
Antécédents médicaux
Thrombose
Symptômes
5
Thrombose
Fausses couches
Variabilité des symptômes
Anticorps anticardiolipines
Grossesse
Fausses couches
Prévention
5
Grossesse
Surveillance médicale
Exercice physique
Thrombose
Alimentation
Santé cardiovasculaire
Traitements
5
Corticostéroïdes
Inflammation
Mode de vie
Prévention des maladies
Transfusion sanguine
Hémorragie
Complications
5
AVC
Anticorps anticardiolipines
Embolie
Complications graves
Qualité de vie
Complications
Facteurs de risque
5
Facteurs de risque
Thrombose
Antécédents familiaux
Maladies auto-immunes
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Anticorps anticardiolipines : Questions médicales les plus fréquentes",
"headline": "Anticorps anticardiolipines : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Anticorps anticardiolipines : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-14",
"dateModified": "2026-05-04",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Anticorps anticardiolipines"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Anticorps antiphospholipides",
"url": "https://questionsmedicales.fr/mesh/D017152",
"about": {
"@type": "MedicalCondition",
"name": "Anticorps antiphospholipides",
"code": {
"@type": "MedicalCode",
"code": "D017152",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.377.715.548.114.323.210"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Anticorps anticardiolipines",
"alternateName": "Antibodies, Anticardiolipin",
"code": {
"@type": "MedicalCode",
"code": "D017153",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Katrien M J Devreese",
"url": "https://questionsmedicales.fr/author/Katrien%20M%20J%20Devreese",
"affiliation": {
"@type": "Organization",
"name": "Coagulation Laboratory, Department of Diagnostic Sciences, Ghent University Hospital, Gent, Belgium."
}
},
{
"@type": "Person",
"name": "Gary W Moore",
"url": "https://questionsmedicales.fr/author/Gary%20W%20Moore",
"affiliation": {
"@type": "Organization",
"name": "Department of Haemostasis and Thrombosis, Viapath Analytics, Guy's & St. Thomas' Hospitals, London, United Kingdom."
}
},
{
"@type": "Person",
"name": "Jean-Christophe Gris",
"url": "https://questionsmedicales.fr/author/Jean-Christophe%20Gris",
"affiliation": {
"@type": "Organization",
"name": "Centre Hospitalier Universitaire de Nîmes et Université de Montpellier, Nîmes, France."
}
},
{
"@type": "Person",
"name": "Jacek Musiał",
"url": "https://questionsmedicales.fr/author/Jacek%20Musia%C5%82",
"affiliation": {
"@type": "Organization",
"name": "Department of Internal Medicine, Allergy and Immunology, Jagiellonian University Medical College, Kraków, Poland."
}
},
{
"@type": "Person",
"name": "Stéphane Zuily",
"url": "https://questionsmedicales.fr/author/St%C3%A9phane%20Zuily",
"affiliation": {
"@type": "Organization",
"name": "Vascular Medicine Division and Regional Competence Center for Rare Vascular and Systemic Autoimmune Diseases, Centre Hospitalier Regional Universitaire de Nancy, Université de Lorraine, Inserm, DCAC, Nancy, France."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Association of anticardiolipin antibodies with epilepsy in children.",
"datePublished": "2023-07-03",
"url": "https://questionsmedicales.fr/article/37981986",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.24294/ti.v7.i1.2021"
}
},
{
"@type": "ScholarlyArticle",
"name": "Anticardiolipin Antibody Determination to Guide Q Fever Treatment.",
"datePublished": "2024-01-08",
"url": "https://questionsmedicales.fr/article/38327944",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.7759/cureus.51840"
}
},
{
"@type": "ScholarlyArticle",
"name": "Antibodies to Domain I β",
"datePublished": "2023-10-13",
"url": "https://questionsmedicales.fr/article/37833609",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1134/S1607672923700278"
}
},
{
"@type": "ScholarlyArticle",
"name": "The clinical relevance of different antiphospholipid antibody profiles in pediatric rheumatology patients.",
"datePublished": "2024-04-26",
"url": "https://questionsmedicales.fr/article/38671480",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12969-024-00954-8"
}
},
{
"@type": "ScholarlyArticle",
"name": "Haematological and other manifestations in the presence of antiphospholipid antibodies in a multicentric paediatric cohort.",
"datePublished": "2023-09-08",
"url": "https://questionsmedicales.fr/article/37706308",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.55563/clinexprheumatol/3mzh06"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Acides aminés, peptides et protéines",
"item": "https://questionsmedicales.fr/mesh/D000602"
},
{
"@type": "ListItem",
"position": 3,
"name": "Protéines",
"item": "https://questionsmedicales.fr/mesh/D011506"
},
{
"@type": "ListItem",
"position": 4,
"name": "Globulines",
"item": "https://questionsmedicales.fr/mesh/D005916"
},
{
"@type": "ListItem",
"position": 5,
"name": "Sérum-globulines",
"item": "https://questionsmedicales.fr/mesh/D012712"
},
{
"@type": "ListItem",
"position": 6,
"name": "Immunoglobulines",
"item": "https://questionsmedicales.fr/mesh/D007136"
},
{
"@type": "ListItem",
"position": 7,
"name": "Anticorps",
"item": "https://questionsmedicales.fr/mesh/D000906"
},
{
"@type": "ListItem",
"position": 8,
"name": "Autoanticorps",
"item": "https://questionsmedicales.fr/mesh/D001323"
},
{
"@type": "ListItem",
"position": 9,
"name": "Anticorps antiphospholipides",
"item": "https://questionsmedicales.fr/mesh/D017152"
},
{
"@type": "ListItem",
"position": 10,
"name": "Anticorps anticardiolipines",
"item": "https://questionsmedicales.fr/mesh/D017153"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Anticorps anticardiolipines - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Anticorps anticardiolipines",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2026-05-14",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Anticorps anticardiolipines",
"description": "Comment diagnostiquer les anticorps anticardiolipines ?\nQuels tests sont utilisés pour les anticorps anticardiolipines ?\nQuels niveaux d'anticorps sont préoccupants ?\nLes anticorps anticardiolipines sont-ils toujours pathologiques ?\nQuel rôle joue l'historique médical dans le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D017153#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Anticorps anticardiolipines",
"description": "Quels symptômes sont associés aux anticorps anticardiolipines ?\nLes anticorps anticardiolipines causent-ils des douleurs ?\nY a-t-il des symptômes neurologiques ?\nLes symptômes varient-ils selon les individus ?\nLes femmes enceintes sont-elles plus à risque ?",
"url": "https://questionsmedicales.fr/mesh/D017153#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Anticorps anticardiolipines",
"description": "Comment prévenir les complications liées aux anticorps ?\nLes femmes enceintes doivent-elles être surveillées ?\nL'exercice physique aide-t-il à prévenir les thromboses ?\nUne alimentation saine est-elle importante ?\nLes médicaments préventifs sont-ils efficaces ?",
"url": "https://questionsmedicales.fr/mesh/D017153#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Anticorps anticardiolipines",
"description": "Quel traitement est recommandé pour les anticorps anticardiolipines ?\nLes corticostéroïdes sont-ils utilisés ?\nY a-t-il des traitements préventifs ?\nLes changements de mode de vie aident-ils ?\nLes transfusions sanguines sont-elles nécessaires ?",
"url": "https://questionsmedicales.fr/mesh/D017153#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Anticorps anticardiolipines",
"description": "Quelles sont les complications possibles des anticorps anticardiolipines ?\nLes AVC sont-ils fréquents chez ces patients ?\nLes complications peuvent-elles être graves ?\nLes complications sont-elles réversibles ?\nLes complications affectent-elles la qualité de vie ?",
"url": "https://questionsmedicales.fr/mesh/D017153#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Anticorps anticardiolipines",
"description": "Quels sont les principaux facteurs de risque ?\nL'âge influence-t-il le risque ?\nLe tabagisme est-il un facteur de risque ?\nLes antécédents familiaux jouent-ils un rôle ?\nLe stress a-t-il un impact sur le risque ?",
"url": "https://questionsmedicales.fr/mesh/D017153#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer les anticorps anticardiolipines ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un test sanguin détecte la présence d'anticorps anticardiolipines."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour les anticorps anticardiolipines ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests ELISA et les tests de coagulation sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "Quels niveaux d'anticorps sont préoccupants ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des niveaux élevés d'anticorps anticardiolipines indiquent un risque accru de thrombose."
}
},
{
"@type": "Question",
"name": "Les anticorps anticardiolipines sont-ils toujours pathologiques ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, leur présence peut être asymptomatique ou liée à d'autres conditions."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'historique médical dans le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'historique de thromboses ou de complications obstétricales est crucial."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont associés aux anticorps anticardiolipines ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des thromboses, des fausses couches et des éruptions cutanées."
}
},
{
"@type": "Question",
"name": "Les anticorps anticardiolipines causent-ils des douleurs ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent être associés à des douleurs dues à des thromboses ou des complications."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes neurologiques ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des AVC ou des migraines peuvent survenir en raison de thromboses cérébrales."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon les individus ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'intensité et la nature des symptômes peuvent varier considérablement."
}
},
{
"@type": "Question",
"name": "Les femmes enceintes sont-elles plus à risque ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent avoir des complications obstétricales comme des fausses couches."
}
},
{
"@type": "Question",
"name": "Comment prévenir les complications liées aux anticorps ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un suivi médical régulier et un traitement préventif sont essentiels."
}
},
{
"@type": "Question",
"name": "Les femmes enceintes doivent-elles être surveillées ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une surveillance étroite est recommandée pour détecter les complications."
}
},
{
"@type": "Question",
"name": "L'exercice physique aide-t-il à prévenir les thromboses ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exercice régulier améliore la circulation sanguine et réduit les risques."
}
},
{
"@type": "Question",
"name": "Une alimentation saine est-elle importante ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation équilibrée peut contribuer à la santé cardiovasculaire."
}
},
{
"@type": "Question",
"name": "Les médicaments préventifs sont-ils efficaces ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les anticoagulants peuvent réduire significativement le risque de thromboses."
}
},
{
"@type": "Question",
"name": "Quel traitement est recommandé pour les anticorps anticardiolipines ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les anticoagulants comme la warfarine sont souvent prescrits pour prévenir les thromboses."
}
},
{
"@type": "Question",
"name": "Les corticostéroïdes sont-ils utilisés ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent être utilisés pour réduire l'inflammation dans certains cas."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements préventifs ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des traitements préventifs sont recommandés pour les femmes enceintes à risque."
}
},
{
"@type": "Question",
"name": "Les changements de mode de vie aident-ils ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sain peut réduire le risque de complications."
}
},
{
"@type": "Question",
"name": "Les transfusions sanguines sont-elles nécessaires ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Rarement, sauf en cas de complications graves comme des hémorragies."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles des anticorps anticardiolipines ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des thromboses, des AVC et des fausses couches."
}
},
{
"@type": "Question",
"name": "Les AVC sont-ils fréquents chez ces patients ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les patients peuvent avoir un risque accru d'AVC ischémique."
}
},
{
"@type": "Question",
"name": "Les complications peuvent-elles être graves ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines complications peuvent mettre en danger la vie, comme des embolies."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles réversibles ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être traitées, mais d'autres peuvent laisser des séquelles."
}
},
{
"@type": "Question",
"name": "Les complications affectent-elles la qualité de vie ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent avoir un impact significatif sur la qualité de vie des patients."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent des antécédents de thromboses, des maladies auto-immunes et la grossesse."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le risque augmente avec l'âge, surtout chez les femmes de plus de 35 ans."
}
},
{
"@type": "Question",
"name": "Le tabagisme est-il un facteur de risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme augmente le risque de thromboses et de complications vasculaires."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux jouent-ils un rôle ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux de maladies auto-immunes peuvent augmenter le risque."
}
},
{
"@type": "Question",
"name": "Le stress a-t-il un impact sur le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut contribuer à des problèmes de santé, y compris des thromboses."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 04/05/2026
Contenu vérifié selon les dernières recommandations médicales
4 publications dans cette catégorie
Affiliations :
Coagulation Laboratory, Department of Diagnostic Sciences, Ghent University Hospital, Gent, Belgium.
Publications dans "Anticorps anticardiolipines" :
3 publications dans cette catégorie
Affiliations :
Department of Haemostasis and Thrombosis, Viapath Analytics, Guy's & St. Thomas' Hospitals, London, United Kingdom.
Publications dans "Anticorps anticardiolipines" :
3 publications dans cette catégorie
Affiliations :
Centre Hospitalier Universitaire de Nîmes et Université de Montpellier, Nîmes, France.
Ivan Sechenov First Moscow State Medical University, Moscow, Russia.
Publications dans "Anticorps anticardiolipines" :
3 publications dans cette catégorie
Affiliations :
Department of Internal Medicine, Allergy and Immunology, Jagiellonian University Medical College, Kraków, Poland.
Publications dans "Anticorps anticardiolipines" :
3 publications dans cette catégorie
Affiliations :
Vascular Medicine Division and Regional Competence Center for Rare Vascular and Systemic Autoimmune Diseases, Centre Hospitalier Regional Universitaire de Nancy, Université de Lorraine, Inserm, DCAC, Nancy, France.
Publications dans "Anticorps anticardiolipines" :
3 publications dans cette catégorie
Affiliations :
Synapse Research Institute, Maastricht, The Netherlands.
Cardiovascular Research Institute Maastricht, Maastricht University Medical Centre, Maastricht, The Netherlands.
Publications dans "Anticorps anticardiolipines" :
2 publications dans cette catégorie
Publications dans "Anticorps anticardiolipines" :
2 publications dans cette catégorie
Affiliations :
CAS Key Laboratory of Mental Health, Institute of Psychology, Beijing, China.
Department of Psychology, University of Chinese Academy of Science, Beijing, China.
Publications dans "Anticorps anticardiolipines" :
2 publications dans cette catégorie
Affiliations :
Synapse Research Institute, Maastricht, The Netherlands.
Cardiovascular Research Institute Maastricht, Maastricht University Medical Centre, Maastricht, The Netherlands.
Publications dans "Anticorps anticardiolipines" :
2 publications dans cette catégorie
Affiliations :
Synapse Research Institute, Maastricht, The Netherlands.
Cardiovascular Research Institute Maastricht, Maastricht University Medical Centre, Maastricht, The Netherlands.
Publications dans "Anticorps anticardiolipines" :
2 publications dans cette catégorie
Affiliations :
Coagulation Laboratory, Ghent University Hospital, Ghent, Belgium.
Department of Diagnostic Sciences, Ghent University, Ghent, Belgium.
Publications dans "Anticorps anticardiolipines" :
2 publications dans cette catégorie
Affiliations :
Vascular Medicine Division and Regional Competence Center for Rare Vascular and Systemic Autoimmune Diseases, Centre Hospitalier Regional Universitaire de Nancy, Université de Lorraine, Inserm, DCAC, Nancy, France.
Publications dans "Anticorps anticardiolipines" :
2 publications dans cette catégorie
Affiliations :
International Center of Excellence in Research, National Institute of Allergy and Infectious Diseases, Phnom Penh, Cambodia.
Publications dans "Anticorps anticardiolipines" :
2 publications dans cette catégorie
Affiliations :
Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States.
Publications dans "Anticorps anticardiolipines" :
2 publications dans cette catégorie
Affiliations :
International Center of Excellence in Research, National Institute of Allergy and Infectious Diseases, Phnom Penh, Cambodia.
Publications dans "Anticorps anticardiolipines" :
2 publications dans cette catégorie
Affiliations :
International Center of Excellence in Research, National Institute of Allergy and Infectious Diseases, Phnom Penh, Cambodia.
Publications dans "Anticorps anticardiolipines" :
2 publications dans cette catégorie
Affiliations :
Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States.
Publications dans "Anticorps anticardiolipines" :
2 publications dans cette catégorie
Affiliations :
Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States.
Publications dans "Anticorps anticardiolipines" :
2 publications dans cette catégorie
Affiliations :
Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States.
Publications dans "Anticorps anticardiolipines" :
2 publications dans cette catégorie
Affiliations :
Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States.
Publications dans "Anticorps anticardiolipines" :
We investigated the association of anticardiolipin antibodies (aCL) with epilepsy development and characteristics in children. This prospective case-control study included 40 epileptic children and 40...
Query (Q) fever is a worldwide infectious disease with acute and chronic manifestations caused by...
The role of antiphospholipid antibodies (aPL), which are not included in the Sydney diagnostic criteria, in antiphospholipid syndrome (APS) and systemic lupus erythematosus (SLE) is poorly understood....
The clinical relevance of different antiphospholipid antibody (aPL) profiles, including low level anticardiolipin (aCL) and anti-β...
In this single center retrospective cohort study, based on the screening of our pediatric (age ≤ 18) rheumatology electronic medical records (2016-2022), we identified patients who had at least one "p...
An initial high-risk aPL profile was persistent in approximately 90% of our cohort, a third of whom had thrombosis, and half had non-thrombotic aPL manifestations. Our results underscore the need for ...
To identify the variables associated with the development of haematological manifestations in the presence of antiphospholipid antibodies (aPLs) in a paediatric cohort....
We conducted a multicentric retrospective cohort study of children under the age of 18 years....
One hundred and thirty-four children were included; 12.2% had at least one thrombotic event (TE) and 67% at least one non-criterion manifestation. Of them, 90% did not develop any TE. Haematological m...
Non-criteria manifestations and among them haematological disorders, are the most frequent events in the presence of aPLs and/or LA in our paediatric cohort. Children with SLE, LA and/or IgG aβ2GPI po...
In this cross-sectional study, it was aimed to test the predictive value of noncriteria antiphospholipid antibodies (aPL) in addition to the global antiphospholipid syndrome score (GAPSS) in predictin...
This study included 50 patients with primary APS, 68 with SLE/APS, and 52 with aPL (+) SLE who were classified according to VT as VT ± pregnancy morbidity (PM), PM only or aPL (+) SLE. Antiphospholipi...
The mean GAPSS and aGAPSS of the study population were 11.6 ± 4.4 and 9.6 ± 3.8. Both the VT ± PM APS (n = 105) and PM only APS (n = 13) groups had significantly higher GAPSS and aGAPSS values compare...
Both the GAPSS and aGAPSS successfully predict the thrombotic risk in aPL (+) patients and aCL IgA, aβ2GPI IgA, and aDI IgG do not contribute to high a GAPSS or aGAPSS....
Thrombosis is a unique complication of coronavirus disease 2019 (COVID-19). Although antiphospholipid antibodies (aPL) are detected in COVID-19 patients, their clinical significance remains elusive. W...
This retrospective single-center nested case-control study included 594 hospitalized patients with COVID-19 between January 2020 and August 2021. Thrombotic complications were collected from medical r...
Among the patients, 31 patients with thrombosis and 62 patients without were compared. The prevalence of any aPLs was indifferent regardless of the thrombosis (41.9% in those with thrombosis...
Although aPLs were frequently detected in Japanese COVID-19 patients, their prevalence and titer were irrelevant to thrombotic complications. While COVID-19 patients have lower levels of serum β2GPI t...
Classification criteria for antiphospholipid syndrome (APS) require IgG or IgM isotypes of the anticardiolipin (aCL) antibodies, anti-β2 glycoprotein I (anti-β2GPI) antibodies, and/or the lupus antico...
This meta-analysis assesses antiphospholipid antibodies' (aPLs) impact on heart valve disease in Systemic Lupus Erythematosus (SLE) patients. We searched PubMed, Embase, Cochrane, and Web of Science u...
The relationship between antiphospholipid syndrome (APS) and acute viral infection, such as SARS-CoV-2, is unclear. This study aims to assess symptoms, antiphospholipid antibody (aPL) fluctuations, an...